A team of surgeons and scientists at University of California, San Diego School of Medicine have developed a new technique that will allow surgeons to identify during surgery which lymph nodes are cancerous so that healthy tissue can be saved. The findings will be published in the January 15 print edition of Cancer Research.
Repression of a single protein in ordinary fibroblasts is sufficient to directly convert the cells into functional neurons. The findings, which could have far-reaching implications for the development of new treatments for neurodegenerative diseases like Huntington’s, Parkinson’s and Alzheimer’s, will be published online in advance of the January 17 issue of the journal Cell.
Researchers from the University of California, San Diego School of Medicine, collaborating with scientists from San Diego-based biotech company ViaCyte, Inc., looked at the differences and similarities between two types of hESC-derived endocrine cell populations and primary human endocrine cells, with the longer-term goal of developing new stem cell therapies for diabetes.
The world is getting a long-awaited first glimpse at a new humanoid robot in action mimicking the expressions of a one-year-old child. The robot will be used in studies on sensory-motor and social development – how babies “learn” to control their bodies and to interact with other people.
The Sulpizio Cardiovascular Center located at University of California, San Diego Health System has been named among "100 Hospitals with Great Heart Programs" by Becker's Hospital Review, a business and legal news publication for hospital and health system leadership.
Where do we come from? What is the universe made of? Will the universe exist only for a finite time or will it last forever? These are just some of the questions that University of California, San Diego physicists are working to answer in the high desert of northern Chile.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
